CDC Panel Recommends Merck's RSV Vaccine for Infants

1 min read
Source: NewsNation
CDC Panel Recommends Merck's RSV Vaccine for Infants
Photo: NewsNation
TL;DR Summary

The CDC's Advisory Committee on Immunization Practices recommended Merck's RSV monoclonal antibody, Enflonsia, for infants, offering a new preventive option against RSV with safety and efficacy demonstrated, potentially impacting public health significantly.

Share this article

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

1 min

vs 2 min read

Condensed

90%

32632 words

Want the full story? Read the original article

Read on NewsNation